Gülben Erdem Huq
Gülben Erdem Huq has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Ayse Sezim Sisman
1 shared publication- Elif Suyanı
Department of Hematology, Adana City Training and Research Hospital, Adana 01230, Türkiye
1 shared publication Engin Acioglu
1 shared publication- Feray Akbas
Department of Internal Medicine, Istanbul Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
1 shared publication - Hilal Tan Köker
Department of Hematolog, Istanbul Education and Training Hospital, İstanbul
1 shared publication - Mehmet Hilmi Dogu
Univ Hlth Sci Turkey, Istanbul Training & Res Hosp, Clin Hematol, Istanbul, Turkey
1 shared publication
Latest Publications
- Open Access
- 29 January 2023
- Published by Balikesir Medical Journal in Balıkesir Medical Journal
- Vol. 7 (1) , 1-14
THE ROLE AND IMPORTANCE OF GALECTIN-3 IN COLON CARCINOMA METASTASIS
Objective: Galectin-3 is an endogenous β-galactoside binding protein which is an S-type lectin family member with intracellular and extracellular localization and has certain tasks for controlling cell adhesion, growth, proliferation, differentiation, migration, and apoptosis. In this study we aimed to elucidate the role of galectin-3 expression in metastasis biology and its role in predicting tumor metastasis in colon carcinomas. Materials and Method: In this research, 80 cases with colon adenocarcinoma containing the transition of the normal mucosa-tumor tissue were included. The expression of galectin-3 in these cases was investigated immuno-histochemically. Results: There was no significant relationship between Galectin-3 expression and age, gender, histological type, and histological grade, but there was a significant increase in the amount of galectin-3 expression while the histological grade increased. Galectin-3 expression of the adjacent normal mucosa and tumor was found to be significantly higher in patients with metastases than patients without metastases. There was also a correlation between the presence of vascular invasion and the increase of galectin-3 expression. The mean galectin-3 expression in metastatic foci was higher than that of the tumor area. These findings suggest that the cells with metastatic phenotype express a higher amount of galectin-3 and also galectin-3 has an indirect role in the pathogenesis of metastasis even if its place could not be determined currently. Conclusion: In our study, it was concluded that the expression of galectin-3 may play a role in the metastatic process of colon carcinomas.
- 29 January 2023
- Published by Balikesir Medical Journal in Balıkesir Medical Journal
- Vol. 7 (1) , 1-14
Open AccessTHE ROLE AND IMPORTANCE OF GALECTIN-3 IN COLON CARCINOMA METASTASIS
Objective: Galectin-3 is an endogenous β-galactoside binding protein which is an S-type lectin family member with intracellular and extracellular localization and has certain tasks for controlling cell adhesion, growth, proliferation, differentiation, migration, and apoptosis. In this study we aimed to elucidate the role of galectin-3 expression in metastasis biology and its role in predicting tumor metastasis in colon carcinomas. Materials and Method: In this research, 80 cases with colon adenocarcinoma containing the transition of the normal mucosa-tumor tissue were included. The expression of galectin-3 in these cases was investigated immuno-histochemically. Results: There was no significant relationship between Galectin-3 expression and age, gender, histological type, and histological grade, but there was a significant increase in the amount of galectin-3 expression while the histological grade increased. Galectin-3 expression of the adjacent normal mucosa and tumor was found to be significantly higher in patients with metastases than patients without metastases. There was also a correlation between the presence of vascular invasion and the increase of galectin-3 expression. The mean galectin-3 expression in metastatic foci was higher than that of the tumor area. These findings suggest that the cells with metastatic phenotype express a higher amount of galectin-3 and also galectin-3 has an indirect role in the pathogenesis of metastasis even if its place could not be determined currently. Conclusion: In our study, it was concluded that the expression of galectin-3 may play a role in the metastatic process of colon carcinomas.
- Open Access
- 25 November 2020
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 21 (1) , 32-35
Primary Spinal Epidural Lymphoma: A Case Report
- 25 November 2020
- Published by Galenos Yayinevi in Istanbul Medical Journal
- Vol. 21 (1) , 32-35
Open AccessPrimary Spinal Epidural Lymphoma: A Case Report
- 24 April 2017
- Published by Springer Nature in Annals of Hematology
- Vol. 96 (8) , 1315-1321
Rethinking the usefulness of bone marrow biopsy on treatment decision in CLL patients at diagnosis
We aimed to investigate the role of bone marrow infiltration pattern (BMIP) and bone marrow reticulin fibrosis (BMRF) in determining treatment demand in patients with diagnosis of chronic lymphocytic leukemia (CLL). We retrospectively evaluated the data of 65 patients, who were followed with the diagnosis of CLL at Istanbul Training and Research Hospital, Department of Hematology, between July 2007 and June 2016. The median age of the patients was 64 years (range, 32–83). Twenty-three (35.4%) patients were female, and 42 (64.6%) were male. Early/mild grade BMRF was observed in 46 (70.8%) patients and advanced grade BMRF in 19 (29.2%) patients. Eleven (23.9%) of 46 patients with early/mild grade BMRF and 10 (52.9%) of 19 patients with advanced grade BMRF required treatment during follow-up (p = 0.04). According to the BMIP, 14 (21.5%) patients had diffuse and 51 (78.5%) patients had non-diffuse BMIP. Eleven (78.6%) of 14 patients with diffuse BMIP and 10 (19.6%) of 51 patients with non-diffuse BMIP required treatment during follow-up (p < 0.001). In univariate analysis, both advanced grade BMRF and diffuse BMIP had an impact on occurrence of treatment demand (p = 0.028, HR = 3.535 vs. p < 0.01 HR = 15.033). Multivariate analysis also revealed diffuse BMIP to be effective (p < 0.001, HR 13.089), while advanced grade BMRF failed to significantly influence treatment demand (p = 0.140, HR 2.664). In conclusion, in the light of our findings, it is reasonable to consider that bone marrow biopsy at the time of diagnosis might provide a preliminary information about treatment demand in patients with CLL.
- 24 April 2017
- Published by Springer Nature in Annals of Hematology
- Vol. 96 (8) , 1315-1321
Rethinking the usefulness of bone marrow biopsy on treatment decision in CLL patients at diagnosis
We aimed to investigate the role of bone marrow infiltration pattern (BMIP) and bone marrow reticulin fibrosis (BMRF) in determining treatment demand in patients with diagnosis of chronic lymphocytic leukemia (CLL). We retrospectively evaluated the data of 65 patients, who were followed with the diagnosis of CLL at Istanbul Training and Research Hospital, Department of Hematology, between July 2007 and June 2016. The median age of the patients was 64 years (range, 32–83). Twenty-three (35.4%) patients were female, and 42 (64.6%) were male. Early/mild grade BMRF was observed in 46 (70.8%) patients and advanced grade BMRF in 19 (29.2%) patients. Eleven (23.9%) of 46 patients with early/mild grade BMRF and 10 (52.9%) of 19 patients with advanced grade BMRF required treatment during follow-up (p = 0.04). According to the BMIP, 14 (21.5%) patients had diffuse and 51 (78.5%) patients had non-diffuse BMIP. Eleven (78.6%) of 14 patients with diffuse BMIP and 10 (19.6%) of 51 patients with non-diffuse BMIP required treatment during follow-up (p < 0.001). In univariate analysis, both advanced grade BMRF and diffuse BMIP had an impact on occurrence of treatment demand (p = 0.028, HR = 3.535 vs. p < 0.01 HR = 15.033). Multivariate analysis also revealed diffuse BMIP to be effective (p < 0.001, HR 13.089), while advanced grade BMRF failed to significantly influence treatment demand (p = 0.140, HR 2.664). In conclusion, in the light of our findings, it is reasonable to consider that bone marrow biopsy at the time of diagnosis might provide a preliminary information about treatment demand in patients with CLL.
- 26 August 2013
- Published by Galenos Yayinevi in Turkish Archives of Otorhinolaryngology
- Vol. 51 (2) , 41-44
Histological Evaluation of the Nasal Swell Body in Allergic Patients
- 26 August 2013
- Published by Galenos Yayinevi in Turkish Archives of Otorhinolaryngology
- Vol. 51 (2) , 41-44
Histological Evaluation of the Nasal Swell Body in Allergic Patients